scholarly article | Q13442814 |
P356 | DOI | 10.1038/S41409-018-0189-2 |
P698 | PubMed publication ID | 29706650 |
P50 | author | Marta Palomo | Q87057029 |
Maria Teresa Cibeira | Q87885213 | ||
Laura Rosiñol | Q87885216 | ||
Joan Bladé | Q87885218 | ||
Alex Bataller | Q88506849 | ||
Enric Carreras | Q90590294 | ||
Montserrat Rovira | Q90625179 | ||
Francesc Fernández-Avilés | Q90625182 | ||
María Suárez-Lledó | Q124079292 | ||
Gonzalo Gutiérrez-García | Q58190510 | ||
Maribel Diaz-Ricart | Q59707025 | ||
Laura Magnano | Q62666471 | ||
P2093 | author name string | Carmen Martínez | |
Ana Moreno | |||
Sofia Jorge | |||
Carlos Fernández de Larrea | |||
Alvaro Urbano-Ispizua | |||
Luis Gerardo Rodríguez-Lobato | |||
Marta Garrote | |||
P2860 | cites work | Regression modeling of competing risk using R: an in depth guide for clinicians | Q82452948 |
Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation | Q82954860 | ||
Divergent effects of novel immunomodulatory agents and cyclophosphamide on the risk of engraftment syndrome after autologous peripheral blood stem cell transplantation for multiple myeloma | Q87012378 | ||
Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT | Q24685958 | ||
Pulmonary manifestations of the pre-engraftment syndrome after umbilical cord blood transplantation | Q33944909 | ||
Engraftment syndrome following hematopoietic stem cell transplantation | Q34298239 | ||
High-dose immunosuppression and hematopoietic stem cell transplantation in autoimmune disease: clinical review | Q34685502 | ||
Induction Therapy with Bortezomib Followed by Bortezomib-High Dose Melphalan and Stem Cell Transplantation for Light Chain Amyloidosis: Results of a Prospective Clinical Trial. | Q35598758 | ||
Survival analysis in hematologic malignancies: recommendations for clinicians | Q36036279 | ||
Engraftment Syndrome after Autologous Stem Cell Transplantation: An Update Unifying the Definition and Management Approach | Q36264701 | ||
Peripheral blood stem cell transplant for POEMS syndrome is associated with high rates of engraftment syndrome | Q36575315 | ||
Pre-engraftment syndrome after myeloablative dual umbilical cord blood transplantation: risk factors and response to treatment | Q36983064 | ||
Optimal use of G-CSF administration after hematopoietic SCT. | Q37442645 | ||
Efficacy of deferred dosing of granulocyte colony-stimulating factor in autologous hematopoietic transplantation for multiple myeloma. | Q37559470 | ||
The role of the endothelium in the short-term complications of hematopoietic SCT. | Q37860915 | ||
Engraftment syndrome: double-edged sword of hematopoietic cell transplants | Q38315390 | ||
Acute kidney injury during leukocyte engraftment after autologous stem cell transplantation in patients with light-chain amyloidosis | Q40306199 | ||
Syngeneic Donor Hematopoietic Stem Cell Transplantation Is Associated with High Rates of Engraftment Syndrome | Q40347834 | ||
Steroids prevent engraftment syndrome after autologous hematopoietic stem cell transplantation without increasing the risk of infection | Q40517545 | ||
Measurement of C-reactive protein in adults with febrile neutropenia after hematopoietic cell transplantation | Q40541991 | ||
Engraftment syndrome following autologous hematopoietic stem cell transplantation: definition of diagnostic criteria | Q40563612 | ||
Engraftment syndrome after autologous hematopoietic stem cell transplant supported by granulocyte-colony-stimulating factor (G-CSF) versus granulocyte-macrophage colony-stimulating factor (GM-CSF). | Q40564199 | ||
Engraftment syndrome: a common cause for rash and fever following autologous hematopoietic stem cell transplantation for multiple sclerosis | Q40588563 | ||
Complications after bone marrow transplantation are manifestations of systemic inflammatory response syndrome | Q40615300 | ||
An engraftment syndrome in autologous stem cell transplantation related to mononuclear cell dose | Q40624714 | ||
Engraftment syndrome after auto-SCT: analysis of diagnostic criteria and risk factors in a large series from a single center | Q43198285 | ||
SCT without growth factor in multiple myeloma: engraftment kinetics, bacteremia and hospitalization | Q43462115 | ||
At-home autologous stem cell transplantation in multiple myeloma with and without G-CSF administration: a comparative study | Q43920667 | ||
The release of soluble factors contributing to endothelial activation and damage after hematopoietic stem cell transplantation is not limited to the allogeneic setting and involves several pathogenic mechanisms. | Q48019681 | ||
Autologous stem cell transplantation in multiple myeloma is not dead but alive and well. | Q48058540 | ||
Engraftment syndrome, the Emperor's new clothes and the artist formerly known as Prince. | Q53628837 | ||
Utility of Comorbidity Assessment in Predicting Transplantation-Related Toxicity Following Autologous Hematopoietic Stem Cell Transplantation for Multiple Myeloma | Q60218172 | ||
Recombinant human granulocyte-macrophage colony-stimulating factor produces fever | Q69916369 | ||
Engraftment syndrome after autologous peripheral blood stem cell transplantation with high numbers of peripheral blood stem cells followed by granulocyte colony-stimulating factor administration | Q73446036 | ||
High CD34 cell doses do not worsen regimen-related toxicity or early mortality after autologous blood stem cell transplantation for breast cancer | Q74219120 | ||
Peri-engraftment respiratory distress syndrome during autologous hematopoietic stem cell transplantation | Q74492531 | ||
Competing risk analysis using R: an easy guide for clinicians | Q80466908 | ||
Serial measurement of serum C-reactive protein levels can identify patients at risk for severe complications following autologous stem cell transplantation | Q81018139 | ||
P433 | issue | 12 | |
P304 | page(s) | 1541-1547 | |
P577 | publication date | 2018-04-29 | |
P1433 | published in | Bone Marrow Transplantation | Q4941523 |
P1476 | title | Innovative strategies minimize engraftment syndrome in multiple myeloma patients with novel induction therapy following autologous hematopoietic stem cell transplantation | |
P478 | volume | 53 |
Search more.